Description
A hydrophobic derivative of deoxynojirimycin that potently inhibits β-glucosidase 2 (IC50 = 0.3 nM), less potently antagonizes glucosylceramide synthase (IC50 = 25 nM), but only poorly inhibits other GCase isoforms; suppresses hapten-induced colitis, enhances insulin sensitivity, and induces SREBP-regulated gene expression and cholesterol synthesis.
Formal name: 2R-(hydroxymethyl)-1-[5-(tricyclo[3.3.2.13,7]dec-1-ylmethoxy)pentyl]-3R,4R,5S-piperidinetriol
Synonyms: Adamantane-pentyl-dNM|AMP-dNM|N-(5-adamantane-1-yl-methoxy-pentyl)-Deoxynojirimycin
Molecular weight: 397.6
CAS: 216758-20-2
Purity: ≥95%
Formulation: A solution in ethanol
Product Type|Biochemicals|Small Molecule Inhibitors|Sphingolipid Turnover||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Immunology & Inflammation|Gastric Disease|Crohn’s Disease||Research Area|Immunology & Inflammation|Gastric Disease|Ulcerative Colitis